Abstract
Surgical emergencies in gynecologic cancers are generally not common and typically involve organs that are not gynecologic in origin. Such systems include pelvic vasculature and nerves, gastrointestinal system, and urologic organs. In addition, wound complications such as wound dehiscence and abdominal compartment syndrome can occur in gynecologic cancer surgeries. The management is similar to other surgical fields and is briefly discussed. This chapter focuses on emergencies that can occur intraoperatively and postoperatively as well as in the setting of medical therapies utilized for gynecologic cancers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parker WH, Wagner WH. Gynecologic surgery and the management of hemorrhage. Obstet Gynecol Clin North Am. 2010;37(3):427–36. doi:10.1016/j.ogc.2010.05.003.
Sharp HT, Swenson C. Hollow viscus injury during surgery. Obstet Gynecol Clin North Am. 2010;37(3):461–7. doi:10.1016/j.ogc.2010.05.004.
Mourton SM, Temple LK, Abu-Rustum NR, Gemignani ML, Sonoda Y, Bochner BH, Barakat RR, Chi DS. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2005;99(3):608–14. doi:10.1016/j.ygyno.2005.07.112.
Richardson DL, Mariani A, Cliby WA. Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol. 2006;103(2):667–72. doi:10.1016/j.ygyno.2006.05.003.
Phitayakorn R, Delaney CP, Reynolds HL, Champagne BJ, Heriot AG, Neary P, Senagore AJ. Standardized algorithms for management of anastomotic leaks and related abdominal and pelvic abscesses after colorectal surgery. World J Surg. 2008;32(6):1147–56. doi:10.1007/s00268-008-9468-1.
Wolff BG, Viscusi ER, Delaney CP, Du W, Techner L. Patterns of gastrointestinal recovery after bowel resection and total abdominal hysterectomy: pooled results from the placebo arms of alvimopan phase III North American clinical trials. J Am Coll Surg. 2007;205(1):43–51. doi:10.1016/j.jamcollsurg.2007.02.026.
Muffly TM, Ridgeway B, Abbott S, Chmielewski L, Falcone T. Small bowel obstruction after hysterectomy to treat benign disease. J Minim Invasive Gynecol. 2012;19(5):615–9. doi:10.1016/j.jmig.2012.05.011.
Bakkum-Gamez JN, Langstraat CL, Martin JR, Lemens MA, Weaver AL, Allensworth S, Dowdy SC, Cliby WA, Gostout BS, Podratz KC. Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma. Gynecol Oncol. 2012;125(3):614–20. doi:10.1016/j.ygyno.2012.02.027.
Bai SW, Huh EH, da Jung J, Park JH, Rha KH, Kim SK, Park KH. Urinary tract injuries during pelvic surgery: incidence rates and predisposing factors. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(4):360–4. doi:10.1007/s00192-005-0015-4.
Cardosi RJ, Cox CS, Hoffman MS. Postoperative neuropathies after major pelvic surgery. Obstet Gynecol. 2002;100(2):240–4.
Vasilev SA. Obturator nerve injury: a review of management options. Gynecol Oncol. 1994;53(2):152–5. doi:10.1006/gyno.1994.1108.
Nezhat FR, Chang-Jackson SC, Acholonu Jr UC, Vetere PF. Robotic-assisted laparoscopic transection and repair of an obturator nerve during pelvic lymphadenectomy for endometrial cancer. Obstet Gynecol. 2012;119(2 Pt 2):462–4. doi:10.1097/AOG.0b013e31823d0c4f.
Zhao W, Jiang W, He C, Tian Y, Wang J. Laparoscopic repair of obturator nerve transection during pelvic lymphadenectomy. Int J Gynaecol Obstet. 2015;129(3):273–4. doi:10.1016/j.ijgo.2015.01.002.
Atema JJ, Gans SL, Boermeester MA. Systematic review and meta-analysis of the open abdomen and temporary abdominal closure techniques in non-trauma patients. World J Surg. 2015;39(4):912–25. doi:10.1007/s00268-014-2883-6.
Carlson GL, Patrick H, Amin AI, McPherson G, MacLennan G, Afolabi E, Mowatt G, Campbell B. Management of the open abdomen: a national study of clinical outcome and safety of negative pressure wound therapy. Ann Surg. 2013;257(6):1154–9. doi:10.1097/SLA.0b013e31828b8bc8.
Bruhin A, Ferreira F, Chariker M, Smith J, Runkel N. Systematic review and evidence based recommendations for the use of negative pressure wound therapy in the open abdomen. Int J Surg. 2014;12(10):1105–14. doi:10.1016/j.ijsu.2014.08.396.
Nguyen VT, Shestak KC. “Separation of anatomic components” method of abdominal wall reconstruction. Oper Tech Gen Surg. 2006;8(4):183–91. doi:10.1053/j.optechgensurg.2006.12.001.
Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain ML, De Keulenaer B, Duchesne J, Bjorck M, Leppaniemi A, Ejike JC, Sugrue M, Cheatham M, Ivatury R, Ball CG, Reintam Blaser A, Regli A, Balogh ZJ, D’Amours S, Debergh D, Kaplan M, Kimball E, Olvera C, Pediatric Guidelines Sub-Committee for the World Society of the Abdominal Compartment Syndrome. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39(7):1190–206. doi:10.1007/s00134-013-2906-z.
Teicher EJ, Pasquale MD, Cipolle MD. Abdominal compartment syndrome. Oper Tech Gen Surg. 2008;10(1):39–59. doi:10.1053/j.optechgensurg.2008.04.001.
Israelsson LA, Millbourn D. Prevention of incisional hernias: how to close a midline incision. Surg Clin North Am. 2013;93(5):1027–40. doi:10.1016/j.suc.2013.06.009.
Barnett JC, Havrilesky LJ, Bondurant AE, Fleming ND, Lee PS, Secord AA, Berchuck A, Valea FA. Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer. Am J Obstet Gynecol. 2011;205(2):143 e141–146. doi:10.1016/j.ajog.2011.03.012.
Ceccaroni M, Berretta R, Malzoni M, Scioscia M, Roviglione G, Spagnolo E, Rolla M, Farina A, Malzoni C, De Iaco P, Minelli L, Bovicelli L. Vaginal cuff dehiscence after hysterectomy: a multicenter retrospective study. Eur J Obstet Gynecol Reprod Biol. 2011;158(2):308–13. doi:10.1016/j.ejogrb.2011.05.013.
Hur HC, Donnellan N, Mansuria S, Barber RE, Guido R, Lee T. Vaginal cuff dehiscence after different modes of hysterectomy. Obstet Gynecol. 2011;118(4):794–801. doi:10.1097/AOG.0b013e31822f1c92.
Uccella S, Ceccaroni M, Cromi A, Malzoni M, Berretta R, De Iaco P, Roviglione G, Bogani G, Minelli L, Ghezzi F. Vaginal cuff dehiscence in a series of 12,398 hysterectomies: effect of different types of colpotomy and vaginal closure. Obstet Gynecol. 2012;120(3):516–23. doi:10.1097/AOG.0b013e318264f848.
Ahmad G, Gent D, Henderson D, O’Flynn H, Phillips K, Watson A. Laparoscopic entry techniques. Cochrane Database Syst Rev. 2015;8:CD006583. doi:10.1002/14651858.CD006583.pub4.
Llarena NC, Shah AB, Milad MP. Bowel injury in gynecologic laparoscopy: a systematic review. Obstet Gynecol. 2015;125(6):1407–17. doi:10.1097/AOG.0000000000000855.
Park EY, Kwon JY, Kim KJ. Carbon dioxide embolism during laparoscopic surgery. Yonsei Med J. 2012;53(3):459–66. doi:10.3349/ymj.2012.53.3.459.
Aghamohammadi H, Mehrabi S, Mohammad Ali Beigi F. Prevention of bradycardia by atropine sulfate during urological laparoscopic surgery: a randomized controlled trial. Urol J. 2009;6(2):92–5.
Cannistra SA, Matulonis UA, Penson RT, Hambleton J, Dupont J, Mackey H, Douglas J, Burger RA, Armstrong D, Wenham R, McGuire W. Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer. J Clin Oncol. 2007;25(33):5180–6. doi:10.1200/jco.2007.12.0782.
Burger RA, Brady MF, Bookman MA, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Fleming GF, Lim PC, Rubin SC, Katsumata N, Liang SX. Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2014;32(12):1210–7. doi:10.1200/jco.2013.53.6524.
Han ES, Monk BJ. What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer? Gynecol Oncol. 2007;105(1):3–6. doi:10.1016/j.ygyno.2007.01.038.
Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stahle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM. A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med. 2011;365(26):2484–96. doi:10.1056/NEJMoa1103799.
Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L, Carcereny E, Ahn MJ, Felip E, Lee JS, Hellmann MD, Hamid O, Goldman JW, Soria JC, Dolled-Filhart M, Rutledge RZ, Zhang J, Lunceford JK, Rangwala R, Lubiniecki GM, Roach C, Emancipator K, Gandhi L. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med. 2015;372(21):2018–28. doi:10.1056/NEJMoa1501824.
Rizvi NA, Mazieres J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet PJ, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, Sanborn R, Lopez-Chavez A, Grohe C, Huber RM, Harbison CT, Baudelet C, Lestini BJ, Ramalingam SS. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol. 2015;16(3):257–65. doi:10.1016/s1470-2045(15)70054-9.
Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, Larkin J, Lorigan P, Neyns B, Blank CU, Hamid O, Mateus C, Shapira-Frommer R, Kosh M, Zhou H, Ibrahim N, Ebbinghaus S, Ribas A. Pembrolizumab versus Ipilimumab in advanced melanoma. N Engl J Med. 2015;372(26):2521–32. doi:10.1056/NEJMoa1503093.
Ring KL, Pakish J, Jazaeri AA. Immune checkpoint inhibitors in the treatment of gynecologic malignancies. Cancer J. 2016;22(2):101–7. doi:10.1097/ppo.0000000000000179.
Klair JS, Girotra M, Hutchins LF, Caradine KD, Aduli F, Garcia-Saenz-de-Sicilia M. Ipilimumab-induced gastrointestinal toxicities: a management algorithm. Dig Dis Sci. 2016;61:2132–9. doi:10.1007/s10620-016-4042-4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Han, E.S., Lee, S., Wakabayashi, M.T. (2017). Surgical Emergencies in Gynecologic Oncology. In: Fong, Y., Kauffmann, R., Marcinkowski, E., Singh, G., Schoellhammer, H. (eds) Surgical Emergencies in the Cancer Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-44025-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-44025-5_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44023-1
Online ISBN: 978-3-319-44025-5
eBook Packages: MedicineMedicine (R0)